Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q3 2026 · 116 positions · Total reported value $2.02B · Top-10 concentration 29.4% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Invenomic Capital Management LP disclosed 116 equity positions with a combined reported value of $2.02B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2026 were UHS ($79.58M), GPN ($68.21M), AMTM ($66.75M). By sector, the heaviest allocations are Consumer Discretionary 28.5%, Technology 26.1%. Versus the prior quarter, allocation shifted toward Industrials (+4.6pp), Consumer Discretionary (+3.3pp) and away from Technology (-2.2pp), Financials (-3.0pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 54% of names.

The largest new positions opened in Q3 2026 were AMTM ($66.75M), GDDY ($56.61M), OCTV ($43.07M).

Of the 35 positions fully exited versus the prior quarter, the largest were BDX ($41.34M), BILL ($32.86M), PATH ($19.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AMTM AMENTUM HOLDINGS INC · $66.75M
  • GDDY GODADDY INC · $56.61M
  • OCTV OCTAVE INTELLIGENCE PLC · $43.07M
  • RRX REGAL REXNORD CORPORATION · $36.28M
  • EFOR EVERFORTH INC · $26.18M
  • NICE NICE LTD · $25.97M
  • BSX BOSTON SCIENTIFIC CORP · $17.02M
  • ZG ZILLOW GROUP INC · $16.85M

Fully Exited (vs previous quarter)

  • BDX BECTON DICKINSON & CO · prev qtr: $41.34M
  • BILL BILL HOLDINGS INC · prev qtr: $32.86M
  • PATH UIPATH INC · prev qtr: $19.43M
  • FIVN FIVE9 INC · prev qtr: $19.03M
  • HAE HAEMONETICS CORP MASS · prev qtr: $16.22M
  • COUR COURSERA INC · prev qtr: $15.78M
  • PRU PRUDENTIAL FINL INC · prev qtr: $14.61M
  • MDT MEDTRONIC PLC · prev qtr: $11.92M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively increasing exposure to industrials, technology, and select consumer discretionary names while trimming some prior positions, suggesting a tactical tilt toward cyclical and growth-oriented sectors. 2. Key moves: - Added: UHS (Health Care), ST (Industrials), OMC (Consumer Discretionary), FIS (Consumer Discretionary), CHTR (Communication Services), PVH (Industrials). - Reduced: GPN (Consumer Discretionary), SPSC (Technology). - New positions: AMTM (Consumer Discretionary), GDDY (Technology). 3. Portfolio structure: Active management with a bias toward industrials, consumer discretionary, and technology; moderate risk appetite evident through concentrated bets (e.g., ST +217.6% QoQ shares). 4. Per-holding one-liner: - UHS: Health care services provider (UNIVERSAL HEALTH SVCS). - GPN: Global payments processor (GLOBAL PMTS). - AMTM: Defense and logistics contractor (AMENTUM HOLDINGS). - ST: Automotive sensor manufacturer (SENSATA TECHNOLOGIES). - GDDY: Web hosting/domain registrar (GODADDY). - OMC: Advertising and marketing services (OMNICOM GROUP). - FIS: Financial tech and services (FIDELITY NATL INFORMATION). - CHTR: Cable and broadband provider (CHARTER COMMUNICATIONS). - PVH: Apparel and footwear (PVH CORPORATION). - SPSC: Industrial automation (SPS COMM). 5. Style summary: The fund tactically rotated into industrials, technology, and high-growth consumer names while trimming select exposures, signaling a bullish cyclical tilt.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 10:14

Sector Allocation

Technology 26.1%
Industrials 14.9%
Health Care 13.8%
Materials 2.7%
Other 3.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 456.66K $79.58M 3.94%
3.94%
Add
2 835.17K $68.21M 3.37%
3.37%
Reduce
3 3.68M $66.75M 3.30%
3.30%
New
4 1.49M $62.07M 3.07%
3.07%
Add
5 592.67K $56.61M 2.80%
2.80%
New
6 747.20K $55.02M 2.72%
2.72%
Add
7 1.65M $54.22M 2.68%
2.68%
Add
8 467.35K $51.83M 2.56%
2.56%
Add
9 676.08K $50.06M 2.48%
2.48%
Add
10 602.29K $49.65M 2.46%
2.46%
Reduce
11 2.28M $43.07M 2.13%
2.13%
New
12 148.51K $40.95M 2.02%
2.02%
Add
13 506.41K $39.73M 1.97%
1.97%
Add
14 579.71K $37.90M 1.87%
1.87%
Add
15 4.20M $37.24M 1.84%
1.84%
Reduce
16 1.38M $36.99M 1.83%
1.83%
Add
17 233.90K $36.28M 1.79%
1.79%
New
18 2.30M $34.59M 1.71%
1.71%
Reduce
19 177.74K $33.85M 1.67%
1.67%
Reduce
20 953.93K $33.54M 1.66%
1.66%
Add
21 347.84K $33.33M 1.65%
1.65%
Add
22 1.49M $32.51M 1.61%
1.61%
Add
23 700.25K $32.37M 1.60%
1.60%
Reduce
24 806.61K $32.24M 1.59%
1.59%
Add
25 18.97M $31.69M 1.57%
1.57%
Add
26 439.72K $29.18M 1.44%
1.44%
Add
27 750.72K $28.90M 1.43%
1.43%
Reduce
28 795.74K $26.18M 1.29%
1.29%
New
29 543.50K $26.14M 1.29%
1.29%
Add
30 233.37K $25.97M 1.28%
1.28%
New
31 159.08K $24.95M 1.23%
1.23%
Reduce
32 505.98K $24.70M 1.22%
1.22%
Add
33 1.87M $23.77M 1.18%
1.18%
Add
34 1.28M $23.33M 1.15%
1.15%
Add
35 632.99K $22.00M 1.09%
1.09%
Add
36 1.56M $21.49M 1.06%
1.06%
Add
37 237.24K $21.07M 1.04%
1.04%
Add
38 2.00M $20.71M 1.02%
1.02%
Reduce
39 1.12M $20.48M 1.01%
1.01%
Add
40 1.07M $19.02M 0.94%
0.94%
Reduce
41 281.39K $18.91M 0.94%
0.94%
Add
42 389.90K $17.02M 0.84%
0.84%
New
43 608.44K $16.85M 0.83%
0.83%
New
44 1.31M $15.21M 0.75%
0.75%
Reduce
45 175.29K $15.13M 0.75%
0.75%
New
46 2.58M $14.47M 0.72%
0.72%
Reduce
47 481.46K $14.42M 0.71%
0.71%
Add
48 1.74M $14.13M 0.70%
0.70%
New
49 238.29K $13.97M 0.69%
0.69%
New
50 581.57K $13.70M 0.68%
0.68%
Add

FAQ

What did Invenomic Capital Management LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Invenomic Capital Management LP reported 116 equity positions worth $2.02B in aggregate; its largest disclosed positions were UHS ($79.58M), GPN ($68.21M), AMTM ($66.75M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.02B of long equity holdings across 116 positions as of 2026-Q3. Top-10 holdings account for 29.4% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →